Arformoterol Tartrate Inhalation Solution
Product Images NDC 76204-026

Product Visual Gallery

This gallery contains 13 technical images submitted to the FDA as part of the official labeling for Arformoterol Tartrate Inhalation Solution (NDC 76204-026). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Ritedose Pharmaceuticals, Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Rdp-arf-30ct-singles (Rdp Arf 30ct Singles Carton)

This text appears to be a description of a medication called Arformoterol Tartrate Inhalation Solution. The medication is available in 2 mL vials, and each vial contains 15 mcg or meg of the active ingredient, arformoterol. The solution is intended for oral inhalation only. It is recommended to keep the medication refrigerated or at room temperature for up to 6 weeks. The text also includes contact information for customer service.*

FDA Label Image

Rdp-arf-60ct-singles (Rdp Arf 60ct Singles Carton)

FDA Label Image

Figure-01 (Figure 01)

FDA Label Image

Figure-02 (Figure 02)

FDA Label Image

Figure-03 (Figure 03)

FDA Label Image

Figure-04 (Figure 04)

FDA Label Image

Figure-05 (Figure 05)

FDA Label Image

Figure-06 (Figure 06)

FDA Label Image

Figure-07 (Figure 07)

FDA Label Image

Figure 08 (Figure 08)

FDA Label Image

Figure-09 (Figure 09)

FDA Label Image

Rdp-01 (Rdp 01)

FDA Label Image

Rdp-02 (Rdp 02)

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.